Fund shareholders of Lineage Cell Therapeutics Inc
ISIN US53566P1093 · United States · LEI 5299002BI4W22SDF8R25
- Fund shareholders
- 17
- Of which ETFs
- 1 16 other funds
- Value held
- 20.6M $
- Share of capital
- 5.0 % of 252.9M shares on Aug 3, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 5,550,504 | 8.8M $ | 0.00 % | 2.19 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 2,580,258 | 4.1M $ | 0.01 % | 1.02 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 1,621,430 | 2.6M $ | 0.03 % | 0.64 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 1,203,122 | 2.3M $ | 0.01 % | 0.48 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 438,359 | 841.6K $ | 0.00 % | 0.17 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 328,879 | 631.4K $ | 0.00 % | 0.13 % | as of Feb 28, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 221,000 | 349.2K $ | 0.28 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 129,818 | 196K $ | 0.00 % | 0.05 % | as of Apr 30, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 118,788 | 179.4K $ | 0.00 % | 0.05 % | as of Apr 30, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 93,589 | 147.9K $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 92,474 | 146.1K $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 80,113 | 121K $ | 0.01 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 79,831 | 126.1K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 34,673 | 52.4K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 26,921 | 40.7K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 4,300 | 6.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 4,135 | 6.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.28 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 0.01 % | as of Apr 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.01 % | as of Feb 28, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 0.01 % | as of Apr 30, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 0.01 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.01 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 0.00 % | as of Mar 31, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 17 | +3 | 12,608,194 | +3.0 % |
| 2026Q1 | 14 | 0 | 12,241,198 | +19.8 % |
| 2025Q4 | 14 | -9 | 10,218,821 | -15.7 % |
| 2025Q3 | 23 | -48 | 12,115,008 | -43.3 % |
| 2025Q2 | 71 | +1 | 21,364,269 | +7.7 % |
| 2025Q1 | 70 | -2 | 19,841,648 | -1.1 % |
| 2024Q4 | 72 | -1 | 20,065,463 | +7.2 % |
| 2024Q3 | 73 | -1 | 18,721,236 | +2.1 % |
| 2024Q2 | 74 | +1 | 18,335,619 | -0.1 % |
| 2024Q1 | 73 | -3 | 18,356,369 | -3.7 % |
| 2023Q4 | 76 | 19,054,892 |
Institutional managers
125 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 49,560,992 | 78.3M $ | as of Mar 31, 2026 |
| Defender Capital, LLC. | 6,729,599 | 10.6M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 5,561,374 | 8.8M $ | as of Mar 31, 2026 |
| RAFFLES ASSOCIATES LP | 5,362,788 | 8.5M $ | as of Mar 31, 2026 |
| FIFTH THIRD BANCORP | 4,600,000 | 7.3M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 3,864,757 | 6.1M $ | as of Mar 31, 2026 |
| ARMISTICE CAPITAL, LLC | 3,182,799 | 5M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 3,065,033 | 4.8M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,523,114 | 4M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 2,125,100 | 3.4M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,868,491 | 3M $ | as of Mar 31, 2026 |
| UBS Group AG | 1,370,461 | 2.2M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1,304,685 | 2.1M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,169,427 | 1.8M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,090,111 | 1.7M $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 993,208 | 1.6M $ | as of Mar 31, 2026 |
| RED CRANE WEALTH MANAGEMENT, LLC | 597,263 | 943.7K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 499,127 | 788.6K $ | as of Mar 31, 2026 |
| SEI INVESTMENTS CO | 422,274 | 667.2K $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 419,355 | 662.6K $ | as of Mar 31, 2026 |
| BARCLAYS PLC | 393,309 | 621.4K $ | as of Mar 31, 2026 |
| Informed Momentum Co LLC | 346,615 | 547.7K $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 304,363 | 480.9K $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 259,561 | 410.1K $ | as of Mar 31, 2026 |
| HRT FINANCIAL LP | 232,264 | 366 $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of Lineage Cell Therapeutics Inc". https://titelia.com/en/stocks/lineage-cell-therapeutics-inc-US53566P1093